Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.42 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.41 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.41 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.41 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.41 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.41 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.41 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 4/20 | 0.41 |
| ▸ | PARP1 | P09874 | 5/20 | 0.39 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL166889 | 1.00 | L3MBTL1 (0.49) | L3MBTL1CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2705793 | 0.95 | CYP2D6 (0.46) | L3MBTL1CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL17529583 | 0.87 | L3MBTL1 (0.49) | L3MBTL1CHRNB2CHRNA7CHRNA4PRKAB2 | |
| Hydrochloric Acid SCHEMBL17514146 | 0.85 | L3MBTL1 (0.48) | L3MBTL1SLC6A2SLC6A4SLC6A3CHRNB2 | |
| SCHEMBL3330878 | 0.84 | L3MBTL1 (0.53) | L3MBTL1CYP2D6CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL30139646 | 0.84 | L3MBTL1 (0.53) | L3MBTL1CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30504206 | 0.84 | L3MBTL1 (0.53) | L3MBTL1CYP2D6CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL6179869 | 0.84 | L3MBTL1 (0.53) | L3MBTL1CYP2D6CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL1713225 | 0.84 | L3MBTL1 (0.53) | L3MBTL1CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6178580 | 0.84 | L3MBTL1 (0.53) | L3MBTL1CYP2D6SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165510-B1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | HOFFMANN LA ROCHE (CH) | 2005-09-28 | — | — | EP | disclosed |
| EP-1165510-A1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-01-02 | — | — | EP | disclosed |
| US-6284785-B1 | HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS | HOFFMANN- LA ROCHE INC. | 2001-09-04 | — | — | US | disclosed |
| WO-2000058285-A1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-10-05 | — | — | WO | disclosed |